CHICAGO, Ill. -- By Shim Hyun-tai/Korea Biomedical Review correspondent - VUNO Inc., a medical AI software company, is highlighting its four main product lines under the concept of “past, present, and future of applying artificial intelligence (AI) in clinical practice,” a top executive said Wednesd
CHICAGO, Ill. -- By Shim Hyun-tai/Korea Biomedical correspondent - The Radiological Society of North America (RSNA) on Monday presented an international study result that about one in 100 hospitalized Covid-19 patients is likely to develop brain complications.On the second day of the annual RSNA mee
CHICAGO, Ill. -- By Shim Hyun-tai/Korea Biomedical correspondent -- The Radiological Society of North America (RSNA), which opened here Sunday for a five-day run at the McCormick Place Convention Center, has prepared AI Showcase for corporate participants.Four Korean biotech companies -- Vuno, Airs
CHICAGO, Ill. -- By Shim Hyun-tai/Korea Biomedical correspondent -- The Radiological Society of North America (RSNA) 2021 open the world’s largest radiological conference despite the Covid-19 pandemic in Chicago, Ill, the U.S., on Sunday.Many biotech companies around the world joined the convention.
As the spread of Covid-19 intensifies amid eased quarantine system, the occupancy rate of hospital beds for critically ill patients in the Seoul metro region is approaching 84 percent.At 5 p.m. Wednesday, the utilization rate of sickbeds for severely ill Covid-19 patients in the greater Seoul area r
Daiichi Sankyo Korea said its hypertension drug Sevikar HCT (ingredient: amlodipine, olmesartan medoxomil, hydrochlorothiazide) showed promising long-term efficacy and safety profile for Korean patients with essential hypertension in RESOLVE-PRO clinical trial.RESOLVE-PRO trial is a real-world study
Celltrion said Wednesday that it would supply Covid-19 antibody treatment, Regkirona (ingredient: regdanvimab), to more facilities treating patients with lighter symptoms to help curb its spread. “Following the decision by Korea Disease Control and Prevention Center (KDCA) to expand the supply of Re
The government said Tuesday it would strengthen quarantine restrictions, possibly holding the current “living with Covid” strategy if the virus spread keeps aggravating. Korea is recording an all-time high figure in the number of severely ill Covid-19 patients, with more and more patients unable to
Alcon Korea, a company specializing in eye care, said it has successfully hosted an online core symposium to share clinical experience and know-how using retinal surgery equipment.The company hosted the meeting to discuss optimal retinal surgery strategies and implementation plans by sharing clinica
A research team of Seoul National University (SNU) has developed a new therapy for rotator cuff disease, a major cause of shoulder pain, with drugs instead of surgery for the first time in the world.Professor Kim Jin-hong of the university’s School of Biological Sciences led the research.Rotator cuf
Seoul National University Hospital (SNUH) said Monday that it would help construct the first national university hospital in Laos.SNUH has signed an agreement to provide consultation for the Lao Ministry of Health concerning establishing the national hospital of the University of Health Sciences of
Genexine said Friday that the company expects its Covid-19 vaccine candidate, GX-19N, to prevent infection for a long time as it uses T cell immune response instead of antibodies.GX-19N, a DNA vaccine, is a next-generation vaccine with nucleocapsid antibody added to the existing spike protein protec
Faced with the rapidly depleting hospital beds in the greater Seoul area, the government has decided to implement the integrated operation of sickbeds among different regions. “The next three weeks will determine whether we can smoothly land on the ‘living with covid” system,” said Lee Ki-il, the fi
Faced with aggravating Covid-19 spread since Korea’s shift to the “living with Covid” strategy, the government will assess the risk every week and decide whether to push ahead with the policy of restoring daily life.“We plan to evaluate Covid-19 risks routinely to monitor the infection trends and ex
BioLeaders said its Covid-19 treatment candidate under joint development with the Korea Mouse Phenotyping Center has shown effective results against the Delta variant in a recent study.The company also conducted a secondary evaluation of the candidate drug’s efficacy at Seoul National University Bun
Yuhan Corp. said it received 11.8 billion won ($9.97 million) of milestone payment as its non-alcoholic steatohepatitis (NASH) therapy licensed out to Boehringer Ingelheim entered the global phase 1 trial.Boehringer Ingelheim has paid Yuhan a total of $50 million as milestone payments since it signe
Korea Pharma said it has concluded a deal to receive the transfer of production technology of iron deficiency anemia therapy, Accrufer (ingredient: ferric maltol), from the U.K.-based Shield Therapeutics.On Tuesday, shield Therapeutics Vice Presidents David Childs and Jackie Mitchell visited Korea P
SK said it plans to sign an exclusive contract by this year-end to invest in The Center for Breakthrough Medicines (CBM), a Philadelphia-based contract development and manufacturing organization (CDMO) specializing in gene and cell therapies.SK expects to emerge as a leading gene and cell therapy CM
Seegene said it has set up Seegene Colombia S.A.S. in Bogota, Colombia, to speed its advance to the Latin American market.It is Seegene’s eighth foreign branch, following those in the U.S., Germany, Italy, the Middle East, Brazil, Canada, and Mexico.Colombia has the third-largest population of 50 mi
Lunit said Monday that it has received clearance from the U.S. Food and Drug Administration for its artificial intelligence (AI)-based image analysis solution, Lunit INSIGHT Triage.Lunit Insight CXR Triage is a solution that automatically classifies normal and abnormal findings of emergency diseases